Literature DB >> 26393449

Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.

Matteo Lambertini1, Francesca Poggio, Alessia Levaggi, Lucia Del Mastro.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26393449     DOI: 10.1097/AOG.0000000000001076

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  5 in total

1.  Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

Authors:  Lucia Del Mastro; Matteo Lambertini
Journal:  Oncologist       Date:  2015-10-13

Review 2.  Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.

Authors:  Matteo Lambertini; Lucia Del Mastro; Giulia Viglietti; Noam F Pondé; Cinzia Solinas; Evandro de Azambuja
Journal:  Curr Treat Options Oncol       Date:  2017-01

3.  The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers.

Authors:  Giovanna Di Emidio; Giulia Rossi; Isabelle Bonomo; Gonzalo Luis Alonso; Roberta Sferra; Antonella Vetuschi; Paolo Giovanni Artini; Alessandro Provenzani; Stefano Falone; Gaspare Carta; Anna Maria D'Alessandro; Fernanda Amicarelli; Carla Tatone
Journal:  Oxid Med Cell Longev       Date:  2017-11-15       Impact factor: 6.543

Review 4.  Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy.

Authors:  Zeev Blumenfeld
Journal:  Clin Med Insights Reprod Health       Date:  2019-08-21

5.  The Oncology Association of Bosnia and Herzegovina's recommendations for fertility preservation in oncologic patients.

Authors:  Timur Cerić; Emir Sokolović; Berisa Hasanbegović; Anes Pašić; Zdenka Gojković; Jelena Vladičić Mašić; Nikolina Dukić; Inga Marijanović; Alma Mekić Abazović; Ibrahim Šišić; Dijana Koprić; Mustafa Hammami; Senad Bajramović; Taib Delić; Semir Bešlija
Journal:  Bosn J Basic Med Sci       Date:  2022-09-16       Impact factor: 3.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.